Annual Meeting

Workshop Presentations

Thursday, December 3, 4:00 pm – 5:30 pm

A-1: A Primer on Antagonist-Based Treatment of Opioid Use Disorders in the Office Setting -Presented by Adam Bisaga, MD

At the end of the workshop participants will be able to:

  • Review evidence supporting the efficacy of naltrexone.
  • Recognize which types of patients are more likely to benefit from opioid antagonist vs. agonist therapy.
  • Examine practical aspects of naltrexone induction and administering injection naltrexone.

A2: Substance Use Disorders and the Cluster B Patient: A Focus on Borderline and Narcissistic Personality Disorders -Presented by Rocco Iannucci, MD

At the end of the workshop participants will be able to:

  •  Identify practical approaches to improve care of those with co-occurring SUDs and BPD or NPD.
  •  Describe methods of diagnosing patients with co-occurring SUDs and personality disorders.
  •  Identify resources to further enhance clinical skills for address    SUDs and personality disorders.

A-3: “I’d Like to Give the VA (& DoD) a Piece of My Mind”- Overcoming Barriers to Evidence-based SUD Care -Presented by Karen Drexler, MD

At the end of the workshop participants will be able to:

  • Learn one (or more) evidence-based practice (EBP) in SUD treatment.
  • Select one or more EBPs to implement in their facility or practice.
  • During workshop, participants and presenters will collaborate to overcome barriers to implementing EBPs.

A4: Treatment of comorbidities in youth and adolescents, presentation of the science and discussion of experience -Presented by David Atkinson, MD

At the end of the workshop participants will be able to:

  • Review evidence regarding treatment of comorbidities.
  • Discuss clinical pitfalls encountered by participants.
  • Explore and share strategic responses to these pitfalls.

A-5: Motivational Interviewing Basics: Brushing up on your skills – Presented by Carla Marienfeld, MD

At the end of the workshop participants will be able to:

  • List the 5 principles of MI, the 4 core skills of MI, and the 3 A’s of MI inconsistent practices.
  • Practice key skills and MI tools in an interactive workshop using small groups and role-play exercise.
  • Discuss the rationale and choices for using MI consistent techniques in everyday clinical care.

Friday, December 4, 10:15 am – 11:45 am

B-1: Approaches to Implementing Medication Assisted Treatments of Opioid Use Disorder in the Community and the Role of PCSS-MAT program -Presented by Frances Levin, MD

At the end of the workshop participants will be able to:

  • Discuss the PCSS-MAT approach.

B2: Clinical Relevance of Glutamate in Alcohol Use Disorder: Pathophysiology to Pharmacotherapy- Presented by Gihyun Yoon, MD

At the end of the workshop participants will be able to:

  • Describe the role of glutamate in the pathophysiology of alcohol use disorder.
  • Discuss pharmacotherapy targeting glutamate system in alcohol use disorder.
  • Improve their pharmacotherapeutic skills in managing patients with alcohol use disorder.

B-3: Interactive Training and Dissemination of Tobacco Cessation in Psychiatry: An Rx for Change- Presented by Smita Das, MD, PhD, and MPH

At the end of the workshop participants will be able to:

  • Review smoking+mental illness epidemiology, medication interactions, nicotine, dual diagnosis.
  • Apply skills including 5As and pharmacotherapy in treatment.
  • Be able to access RxforChange, a web based curriculum to disseminate tobacco treatment training.

B4: Big Data, Precision Medicine and Addiction Psychiatry: Practical Concepts and Pitfalls- Presented by Sean Luo, MD, PhD

At the end of the workshop participants will be able to:

  • Summarize a few projects in Precision Addiction Medicine.
  • Review possible ideas for future projects and applications.
  • Examine and assess demonstrations of existing/future products.

B-5: Addictive Behaviors in Organ Transplantation Patients- Presented by Paula Zimbrean, MD

At the end of the workshop participants will be able to:

  • Discuss the impact of addictive disorders on organ transplantation outcomes.
  • Describe the role of the addiction psychiatrist in organ transplantation.
  • Review addiction treatment in the transplant setting.

Saturday, December 5, 10:15 am – 11:45 am

C-1: Substance Use Among Refugees and Displaced Populations: Clinical and Research Considerations- Presented by Hussam Jefee-Bahloul, MD

At the end of the workshop participants will be able to:

  • Understand the psychosocial stressors unique to displaced populations.
  • Understand the relationship between displacement, trauma and substance use disorders in this population.
  • Identify barriers and facilitators of treatment approaches for substance use and related harm among refugees and displaced populations.
  • Identify specific research-related themes when studying substance use disorders in this population.

C-2: Clinical Application of Recent Research Findings on Alcoholics Anonymous- Presented by Marc Galanter, MD

At the end of the workshop participants will be able to:

  • Imparting clinically relevant recent research.
  • Discussing patient management issues associated with the research.
  • Enabling participants to apply discussion of these issues to improving their practices.

C-3: Acceptance and Commitment Therapy for Addictions – Presented by John Matthews, MD, MSc

At the end of the workshop participants will be able to:

  • Describe the differences in treatment approaches between CBT and ACT.
  • Cite studies demonstrating the efficacy of ACT in treating addictions.
  • Cite and apply the six ACT processes for psychological flexibility.

C4: Benzodiazepine Taper in Anxious Patients: Pharmacological and Behavioral Treatment Approaches- Presented by Olivera Bogunovic, MD

At the end of the workshop participants will be able to:

  • Identify benzodiazepine dependence and benzodiazepine withdrawal symptoms.
  • Describe benzodiazepine tapering strategies on an outpatient basis.
  • Identify concrete behavioral strategies for the management of rebound anxiety during taper.

C-5: Implementing the evidence based Women’s Recovery Group Treatment for Substance Disorders in your Practice Setting -Presented by Shelly Greenfield, MD, MPH

At the end of the workshop participants will be able to:

  • Describe how gender-responsive treatment is helpful for women with substance use disorders.
  • Identify the gender-responsive components of the Women’s Recovery Group.
  • Identify and problem solve common issues implementing the Women’s Recovery Group in their practice.